News | May 12, 2023
Gilead acquires XinThera to strengthen pipeline in oncology
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
Lucid-MS is a new drug candidate for the treatment of multiple sclerosis
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
Subscribe To Our Newsletter & Stay Updated
